These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33675094)

  • 1. Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development.
    Liang YJ; Teng W; Chen CL; Sun CP; Teng RD; Huang YH; Liang KH; Chen YW; Lin CC; Su CW; Tao MH; Wu JC
    Hepatology; 2021 Aug; 74(2):641-655. PubMed ID: 33675094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
    Gil-García AI; Madejón A; Francisco-Recuero I; López-López A; Villafranca E; Romero M; García A; Olveira A; Mena R; Larrubia JR; García-Samaniego J
    World J Gastroenterol; 2019 Oct; 25(38):5883-5896. PubMed ID: 31636479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PreS deletion profiles of hepatitis B virus (HBV) are associated with clinical presentations of chronic HBV infection.
    Li X; Qin Y; Liu Y; Li F; Liao H; Lu S; Qiao Y; Xu D; Li J
    J Clin Virol; 2016 Sep; 82():27-32. PubMed ID: 27415434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the HBV PreS/S gene related to hepatocellular carcinoma in Vietnamese chronic HBV-infected patients.
    Thi Cam Huong N; Trung NQ; Luong BA; Tram DB; Vu HA; Bui HH; Pham Thi Le H
    PLoS One; 2022; 17(4):e0266134. PubMed ID: 35390033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a hepatitis B virus pre-S2 deletion mutant in the liver results in hepatomegaly and hepatocellular carcinoma in mice.
    Teng YC; Neo JC; Wu JC; Chen YF; Kao CH; Tsai TF
    J Pathol; 2017 Mar; 241(4):463-474. PubMed ID: 27868197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma and hepatitis B surface protein.
    Li YW; Yang FC; Lu HQ; Zhang JS
    World J Gastroenterol; 2016 Feb; 22(6):1943-52. PubMed ID: 26877602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma.
    Yin J; Xie J; Zhang H; Shen Q; Han L; Lu W; Han Y; Li C; Ni W; Wang H; Cao G
    J Gastroenterol; 2010 Oct; 45(10):1063-71. PubMed ID: 20419326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: Association between hepatitis B virus preS mutation and hepatocellular carcinoma risk.
    Wungu CDK; Ariyanto FC; Prabowo GI; Soetjipto S; Handajani R
    J Viral Hepat; 2021 Jan; 28(1):61-71. PubMed ID: 32896077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.
    Pollicino T; Amaddeo G; Restuccia A; Raffa G; Alibrandi A; Cutroneo G; Favaloro A; Maimone S; Squadrito G; Raimondo G
    Hepatology; 2012 Aug; 56(2):434-43. PubMed ID: 22271491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment.
    Zhang D; Dong P; Zhang K; Deng L; Bach C; Chen W; Li F; Protzer U; Ding H; Zeng C
    BMC Microbiol; 2012 Dec; 12():307. PubMed ID: 23272650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma.
    Yuen MF; Wong DK; Fung J; Ip P; But D; Hung I; Lau K; Yuen JC; Lai CL
    Gastroenterology; 2008 Oct; 135(4):1192-9. PubMed ID: 18722377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma.
    Gao ZY; Li T; Wang J; Du JM; Li YJ; Li J; Lu FM; Zhuang H
    J Gastroenterol; 2007 Sep; 42(9):761-8. PubMed ID: 17876546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
    Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
    J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naturally Occurring Hepatitis B Virus Mutations Leading to Endoplasmic Reticulum Stress and Their Contribution to the Progression of Hepatocellular Carcinoma.
    Choi YM; Lee SY; Kim BJ
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing.
    Wang Y; Xiao X; Chen S; Huang C; Zhou J; Dai E; Li Y; Liu L; Huang X; Gao Z; Wu C; Fang M; Gao C
    Front Immunol; 2021; 12():775461. PubMed ID: 34899733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.
    Hsu HY; Chang MH; Ni YH; Jeng YM; Chiang CL; Chen HL; Wu JF; Chen PJ
    J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of novel mutations and haplotypes in the preS region of hepatitis B virus with hepatocellular carcinoma.
    Xie JX; Zhao J; Yin JH; Zhang Q; Pu R; Lu WY; Zhang HW; Wang HY; Cao GW
    Front Med China; 2010 Dec; 4(4):419-29. PubMed ID: 21104161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult infection with hepatitis B virus PreS variants synergistically promotes hepatocellular carcinoma development in a high-fat diet context by generating abnormal ceramides.
    Liu C; Chen K; Zhao F; Xuan L; Wang Y; Xu C; Wu Z; Wang D; Qu C
    BMC Med; 2022 Sep; 20(1):279. PubMed ID: 36058909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro.
    Salpini R; Surdo M; Warner N; Cortese MF; Colledge D; Soppe S; Bellocchi MC; Armenia D; Carioti L; Continenza F; Di Carlo D; Saccomandi P; Mirabelli C; Pollicita M; Longo R; Romano S; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Iapadre N; Barlattani A; Bertoli A; Mari T; Pasquazzi C; Missale G; Sarrecchia C; Orecchini E; Michienzi A; Andreoni M; Francioso S; Angelico M; Verheyen J; Ceccherini-Silberstein F; Locarnini S; Perno CF; Svicher V
    Oncotarget; 2017 Feb; 8(9):15704-15715. PubMed ID: 28152517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.